Tag: tolerability

Commercial & Investment Banking Picture Gallery

First-In-Human Assessment of LB-100, Lixte Biotechnology–s Protein Phosphatase 2A Inhibitor, Published in Clinical Cancer Research

January 4, 2017
Presse

EAST SETAUKET, NY -- (Marketwired) -- 01/04/17 -- Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT) announced the…

Continue Reading